AMAG Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results for the Third Quarter on October 28, 2010 at 5:30 p.m. ET

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it will report unaudited consolidated financial results for the quarter ended September 30, 2010 after the U.S. financial markets close on October 28, 2010. The announcement will be followed by a conference call and webcast with slides at 5:30 p.m. ET during which management will discuss the company’s financial results, business highlights, commercial progress and development programs and provide an update on recent discussions with the U.S. Food and Drug Administration regarding the package insert for Feraheme® (ferumoxytol) Injection for intravenous (IV) use.